Metastasis to the breast from an adenocarcinoma of the lung with extensive micropapillary component: a case report and review of the literature
- Nicoletta Maounis†1, 2Email author,
- Maria Chorti†3,
- Stella Legaki3,
- Eleni Ellina1,
- Aphrodite Emmanouilidou1,
- Maria Demonakou3 and
- Xanthi Tsiafaki4
© Maounis et al; licensee BioMed Central Ltd. 2010
Received: 18 October 2010
Accepted: 17 December 2010
Published: 17 December 2010
Breast metastasis from extra-mammary malignancy is rare. Based on the literature an incidence of 0.4-1.3% is reported. The primary malignancies most commonly metastasizing to the breast are leukemia-lymphoma, and malignant melanoma. We present a case of metastasis to the breast from a pulmonary adenocarcinoma, with extensive micropapillary component, diagnosed concomitantly with the primary tumor. A 73-year-old female presented with dyspnea and dry cough of 4 weeks duration and a massive pleural effusion was found on a chest radiograph. Additionally, on physical examination a poorly defined mass was noted in the upper outer quadrant of the left breast. The patient underwent bronchoscopy, excisional breast biopsy and medical thoracoscopy. By cytology, histology and immunohistochemistry primary lung adenocarcinoma with metastasis to the breast and parietal pleura was diagnosed. Both the primary and metastatic anatomic sites demonstrated histologically extensive micropapillary component, which is recently recognized as an important prognostic factor. The patient received chemotherapy but passed away within 7 months. Accurate differentiation of metastatic from primary carcinoma is of crucial importance because the treatment and prognosis differ significantly.
The National Cancer Institute of the U.S.A. estimates, that based on current rates, 12.7% of women born today will be diagnosed with breast cancer in their life time . Although, primary breast cancer is the most common malignancy of adult females, metastatic involvement of the breast is rare with a reported frequency of 0.4 - 1.3% in clinical series [2–5]. Despite its rarity, metastatic disease to the breast is an important diagnostic clinical dilemma, because its treatment differs greatly from that of primary breast cancer.
Sitzentfrey, in 1907, was the first to publish a case of ovarian carcinoma metastatic to the breast . Since then a wide variety of malignancies have been reported to metastasize to the breast and according to the literature the most common primary tumors are melanomas and haematological malignancies [5, 7]. Despite the fact that the lung is the most common cancer site in terms of incidence and mortality there are only few published cases on pulmonary carcinomas metastasizing to the breast [8–12].
Carcinomas with micropapillary components have been reported at several anatomical sites, including the breast, urinary bladder, ovary and major salivary glands . The micropapillary component is being increasingly recognized as a prognostic predictor in lung adenocarcinomas and according to many authors it may be a manifestation of aggressive behaviour [14, 15]. We report a patient with metastasis to the breast from a pulmonary adenocarcinoma with extensive micropapillary pattern diagnosed concomitantly with the primary tumor.
The mediastinum and the trachea were severely displaced to the right. A few lymph nodes deeply in the left axilla and some paratracheal lymph nodes were observed. Clinically the diagnosis was considered to be either a primary breast tumor with lung and pleural metastasis or two synchronous primaries. Mammography showed diffuse asymmetrical density in the subalveolar region and the upper outer quadrant of the left breast. (Figure1c). Additionally, skin thickening was demonstrated in the affected area. Calcifications were not observed. The differential diagnosis included inflammation, lymphoma and inflammatory breast carcinoma. Excisional biopsy was recommended.
Moreover, the patient underwent bronchoscopy which revealed submucosal infiltration causing widening of the secondary carina and obstruction of the orifice of the lingula at approximately 70%. Pleural effusion re-accumulated rapidly so in order to perform pleural drainage and chemical pleurodesis medical thoracoscopy was carried out. During the procedure biopsies were obtained from the parietal pleura. Chest computed tomography (Figure 1d) followed and showed a 3,5 × 4,5 cm peripheral lesion, on the left upper lobe, with relative abnormal contour and extension into the surrounding parenchyma. The tumor was in contact to the splanchnic pleura and approached the parietal pleura, possibly invading it. Finally, an excisional breast biopsy was performed.
Our patient received 4 courses of Bevacizumab, Cisplatin and Docetaxel with no clinical response. Unfortunately the patient died 6 months following diagnosis.
Cytologic and Immunocytochemical findings
Antibodies employed in the immunohistochemistry applied
Dako, Glostrup, Denmark
Dako, Glostrup, Denmark
Dako, Glostrup, Denmark
Dako, Glostrup, Denmark
NeoMarkers, Fremont, CA, USA
Dako, Glostrup, Denmark
Dako, Glostrup, Denmark
Dako, Glostrup, Denmark
Dako, Glostrup, Denmark
Dako, Glostrup, Denmark
NeoMarkers, CA, USA
Histopathological and Immunohistochemical findings
Worldwide, lung cancer is the most common cancer in terms of both incidence and mortality (1.6 million new cases per year and 1.378 million deaths) . Approximately one fifth, of newly diagnosed lung adenocarcinomas, present with distant metastases. The most common sites of metastasis are brain, bone, liver, and adrenal glands, in decreasing order. However autopsy series have demonstrated that NSCLCs may spread to virtually any organ.
Breast metastases from extra-mammary malignancies are rare accounting for 0.4 to 1.3% of all breast malignancies [2–5]. Nearly 700 cases have been reported in small series and case reports [2–5, 7, 12, 16, 17].
According to the international literature the most common sources of primary tumors were haematological malignancies, malignant melanoma, lung tumors, renal cell carcinoma, ovarian tumors, thyroid carcinomas and small bowel carcinoids [3, 7, 17]. Williams et al in the largest published series of 169 cases with metastases to the breast from extramammary solid tumors reported that the most common histological type was malignant melanoma .
Review of the literature (1990-2010) includes approximately 30 NSCLCs as case reports or part of a series of secondary breast tumors [4, 5, 9–12, 18–26]. Twelve of the above cases were classified as adenocarcinomas [5, 9, 12, 18, 20–22, 24]. Additionally, 53 cases of breast metastasis from lung tumors were presented however, no detailed histological classification was provided [7, 17, 27–29]. The majority of breast metastases present as palpable, rapidly growing, well circumscribed, painless breast masses with predilection to the upper outer quadrant [2, 7, 12, 16, 21]. Unlike primary tumors, in the vast majority of metastases retraction of the skin or nipple is not demonstrated despite their superficial location [5, 21]. However, in our patient, the lesion was poorly defined and skin redness was observed. Other authors have rarely reported similar findings [7, 16, 24, 29].
Distinguishing a breast metastasis from a primary mammary adenocarcinoma, based on mammographic findings, may be extremely difficult because of the wide range of imaging manifestations of the metastatic lesion [4, 5, 17]. Thus, metastasis can mimic a primary malignancy or even a benign breast tumor [4, 5, 17]. The most commonly described mammographic presentation is usually single but sometimes multiple well circumscribed lesions with smooth margins [3, 17, 29]. Microcalcifications are very uncommon but have been reported in patients with metastatic serous ovarian papillary carcinoma [17, 28, 29]. In our case, mammography showed diffuse asymmetrical density and skin thickening. In cases such as ours the differential diagnosis includes inflammation, lymphoma and inflammatory breast carcinoma.
As sited in the literature, histological features that may aid in the recognition of secondary tumors are the following: The absence of in situ carcinoma strongly supports a metastatic tumor, although it may not be present in all primary invasive carcinomas. Additionally, metastatic malignancies are often sharply circumscribed from the surrounding breast tissue. Furthermore, elastosis is common in primary tumors but rare in extramammary malignancies [2, 4, 5, 12, 18]. Occasionally, metastases to the breast demonstrate features that can lead pathologists to the correct diagnosis such as presence of pigmentation and intranuclear inclusions in malignant melanomas. Nevertheless, many extramammary malignancies such as adenocarcinoma of the lung lack specific histological features.
Carcinomas with a micropapillary component have been described in many organs including the breast, urinary bladder, ovary and salivary glands . Amin et al. in 2002, was the first to report lung adenocarcinomas with micropapillary component . Histologically, the latter is characterized by small papillary tufts lying freely within alveolar spaces or encased within the thin walls of connective tissue. These small, cohesive nests lack fibrovascular connective tissue cores . In our case all biopsies examined demonstrated an extensive micropapillary component. Although psammoma bodies have not been observed in invasive micropapillary pattern carcinoma of the urinary bladder and salivary glands they have rarely been reported in cases of lung adenocarcinoma with micropapillary morphology [13, 14, 30]. Multiple psammoma bodies were demonstrated in the tissue sections of our samples examined. To the best of our knowledge this is the first report of a breast metastasis from lung adenocarcinoma with micropapillary pattern diagnosed concomitantly with the primary tumor.
The distinction between metastasis from lung adenocarcinoma, particularly with extensive micropapillary pattern, and primary mammary adenocarcinoma may cause a significant diagnostic dilemma. The contribution of immunohistochemstry to the correct diagnosis is crucial.
TTF-1 is expressed in 68-80% of lung adenocarcinomas, and besides a single case published by Klingen TA et al, has never been reported to stain positive in breast adenocarcinoma [31–33]. The sensitivity of SP-A is substantially less. It is expressed in approximately 45% of lung adenocarcinomas [32, 33]. A negative expression of thyroglobulin excludes the diagnosis of papillary carcinoma of the thyroid, which stains positive to both markers. ERs are expressed in 80% and GCDFP-15 in 45-53% of breast carcinomas [32, 34]. As recently published, ER expression in the lung adenocarcinoma, by using the monoclonal antibodies 1D5 and 6F11 is low (7,6-14,1%) [32, 35]. Additionally, 5,2-15% of lung adenocarcinomas express GCDFP-15 [34, 36]. Finally, mammaglobin is expressed in 48-72,1% of mammary adenocarcinomas but stains negative in pulmonary adenocarcinomas [32, 34, 37]. Consequently, a panel of markers must be used as no single antibody is 100% sensitive and false negative results do occur. In our case, all the tumor specimens (lung, pleura and breast) showed positive nuclear staining for TTF-1 and cytoplasmic staining for SP-A. The neoplastic cells lacked expression of GCDFP-15, ER and mammaglobin.
Overall metastasis to the breast has been associated with poor prognosis with most patients dying within a year of diagnosis . Our patient survived 6 months following the diagnosis of both the primary lung tumor and the breast metastasis.
We reported a rare case of metastasis to the breast from an adenocarcinoma of the lung with extensive micropapillary component. Metastatic disease to the breast, although rare, should be considered in the differential diagnosis of a primary mammary carcinoma because the treatment and prognosis differ significantly. Furthermore, the distinction between metastasis from lung adenocarcinoma, particularly with extensive micropapillary pattern, and primary breast adenocarcinoma may cause a significant diagnostic dilemma. The contribution of immunohistochemstry to the correct diagnosis is very important.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in Chief of this Journal.
- National cancer institute. Probability of breast cancer in American women: --- Either ISSN or Journal title must be supplied.. [http://www.cancer.gov/cancertopics/factsheet/detection/probability-breast-cancer]
- Hajdu SI, Urban JA: Cancers metastatic to the breast. Cancer. 1972, 29: 1691-1696. 10.1002/1097-0142(197206)29:6<1691::AID-CNCR2820290637>3.0.CO;2-4.View ArticlePubMedGoogle Scholar
- Vizcaíno I, Torregrosa A, Higueras V, Morote V, Cremades A, Torres V, Olmos S, Molins C: Metastasis to the breast from extramammary malignancies: a report of four cases and a review of literature. Eur Radiol. 2001, 11: 1659-1665.View ArticlePubMedGoogle Scholar
- Georgiannos SN, Aleong JC, Goode AW, Sheaff M: Secondary neoplasms of the breast: a survey of the 20th century. Cancer. 2001, 92: 2259-2266. 10.1002/1097-0142(20011101)92:9<2259::AID-CNCR1571>3.0.CO;2-O.View ArticlePubMedGoogle Scholar
- Klingen TA, Klaasen H, Aas H, Chen Y, Akslen LA: Secondary breast cancer: a 5-year population-based study with review of the literature. APMIS. 2009, 117: 762-767. 10.1111/j.1600-0463.2009.02529.x.View ArticlePubMedGoogle Scholar
- Sitzenfrey A: Mammakarzinom zwei jahre nach abdominaler radikal operation wegen doppelseitigen carcinoma ovarii. Prag Med Wochenschr. 1907, 32: 221-235.Google Scholar
- Williams SA, Ehlers RA, Hunt KK, Yi M, Kuerer HM, Singletary SE, Ross MI, Feig BW, Symmans WF, Meric-Bernstam F: Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer. 2007, 110: 731-737. 10.1002/cncr.22835.View ArticlePubMedGoogle Scholar
- International agency for research on cancer: --- Either ISSN or Journal title must be supplied.. [http://globocan.iarc.fr]
- Masmoudi A, Mathieu MC, Soria JC: Breast metastasis from lung adenocarcinoma: a case report. Anticancer Res. 2003, 23: 1825-1826.PubMedGoogle Scholar
- Ramar K, Pervez H, Potti A, Mehdi S: Breast metastasis from non-small-cell lung carcinoma. Med Oncol. 2003, 20: 181-184. 10.1385/MO:20:2:181.View ArticlePubMedGoogle Scholar
- Gómez-Caro A, Piñero A, Roca MJ, Torres J, Ferri B, Galindo PJ, Parrilla P: Surgical treatment of solitary metastasis in the male breast from non-small cell lung cancer. Breast J. 2006, 12: 366-367.View ArticlePubMedGoogle Scholar
- Lee AHS: The histological diagnosis of metastases to the breast from extramammary malignancies. J Clin Pathol. 2007, 60: 1333-1341. 10.1136/jcp.2006.046078.PubMed CentralView ArticlePubMedGoogle Scholar
- Nassar H: Carcinomas with micropapillary morphology: clinical significance and current concepts. Adv Anat Pathol. 2004, 11: 297-303. 10.1097/01.pap.0000138142.26882.fe.View ArticlePubMedGoogle Scholar
- Amin MB, Tamboli P, Merchant SH, Ordóñez NG, Ro J, Ayala AG, Ro JY: Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol. 2002, 26: 358-364. 10.1097/00000478-200203000-00010.View ArticlePubMedGoogle Scholar
- Maeda R, Isowa N, Onuma N, Miura H, Harada T, Touge H, Tokuyasu H, Kawasaki Y: Lung adenocarcinomas with micropapillary components. Gen Thorac Cardiovasc Surg. 2009, 10: 534-539. 10.1007/s11748-009-0436-y.View ArticleGoogle Scholar
- Toombs BD, Kalisher L: Metastatic disease to the breast: clinical, pathologic and radiographic features. Am J Roentgenol. 1977, 129: 673-676.View ArticleGoogle Scholar
- Noguera JJ, Martínez-Miravete P, Idoate F, Diaz L, Pina L, Zornoza G, Martínez-Regueira F: Metastases to the breast: A review of 33 cases. Australas Radiol. 2007, 51: 133-138. 10.1111/j.1440-1673.2007.01681.x.View ArticlePubMedGoogle Scholar
- Verger E, Conill C, Velasco M, Sole M: Metastasis in the male breast from a lung adenocarcinoma. Acta Oncol. 1992, 31: 479-10.3109/02841869209088294.View ArticlePubMedGoogle Scholar
- Sadikot RT, Renwick DS, DaCosta P, Chalmers AG, Pearson SB: Breast metastasis from non-small cell lung cancer. South Med J. 1997, 90: 1063-1064. 10.1097/00007611-199710000-00021.View ArticlePubMedGoogle Scholar
- Lee SH, Park JM, Kook SH, Han BK, Moon WK: Metastatic tumors to the breast: mammographic and ultrasonographic findings. J Ultrasound Med. 2000, 19: 257-262.PubMedGoogle Scholar
- Yeh CN, Lin CH, Chen MF: Clinical and ultrasonographic characteristics of breast metastases from extramammary malignancies. Am Surg. 2004, 70: 287-290.PubMedGoogle Scholar
- Komorowski AL, Wysocki WM, Mitus J: Metastasis to the breast - a clinical challenge in outpatient. Acta Chir Belg. 2005, 105: 59-61.PubMedGoogle Scholar
- Ucar N, Kurt OK, Alpar S, Orsel O, Demirag F, Kurt B: Breast metastasis in a male patient with nonsmall cell lung carcinoma. South Med J. 2007, 100: 850-851.View ArticlePubMedGoogle Scholar
- Fulcinity F, Losito S, Botti G, Di Mattia D, La Mura A, Pisano C, Pignata S: Metastases to the breast: role of fine needle cytology samples. Our experience with nine cases in 2 years. Ann Oncol. 2008, 19: 682-687. 10.1093/annonc/mdm546.View ArticleGoogle Scholar
- Hsu W, Sheen-Chen SM, Wang JL, Huang CC, Ko SF: Squamous cell lung carcinoma metastatic to the breast. Anticancer Res. 2008, 28: 1299-1301.PubMedGoogle Scholar
- Wood B, Sterrett G, Frost F, Swarbrick N: Diagnosis of extramammary malignancy metastatic to the breast by fine needle biopsy. Pathology. 2008, 40: 345-351. 10.1080/00313020801911520.View ArticlePubMedGoogle Scholar
- Nielsen M, Andersen JA, Henriksen FW, Kristensen PB, Lorentzen M, Ravn V, Schiodt T, Thornborg JV, Ornvold K: Metastases to the breast from extramammary carcinomas. Acta Pathol Microbiol Scand A. 1981, 89: 251-256.PubMedGoogle Scholar
- Muttarak M, Nimmonrat A, Chaiwun B: Metastatic carcinoma to the male and female breast. Australas Radiol. 1998, 42: 16-19. 10.1111/j.1440-1673.1998.tb00556.x.View ArticlePubMedGoogle Scholar
- Lee SK, Kim WW, Kim SH, Hur SM, Kim S, Choi JH, Cho EY, Han SY, Hahn BK, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH: Characteristics of metastasis in the breast from extramammary malignancies. J Surg Oncol. 2010, 101: 137-140. 10.1002/jso.21453.View ArticlePubMedGoogle Scholar
- Kuroda N, Hamaguchi N, Takeuchi E, Ohara M, Hirouchi T, Mizuno K: Lung adenocarcinoma with micropapillary pattern: a clinicopathological study of 25 cases. APMIS. 2006, 114: 381-5. 10.1111/j.1600-0463.2006.apm_340.x.View ArticlePubMedGoogle Scholar
- Klingen TA, Chen Y, Gundersen MD, Aas H, Westre B, Sauer T: Thyroid trascription factor-1 positive primary breast cancer: a case report with review of the literature. Diagn Pathol. 2010, 5: 37-10.1186/1746-1596-5-37.PubMed CentralView ArticlePubMedGoogle Scholar
- Yang M, Nonaka D: A stydy of immunohistochemical differential expression in pulmonary and mammary carcinomas. Mod Pathol. 2010, 23: 654-661. 10.1038/modpathol.2010.38.View ArticlePubMedGoogle Scholar
- Zamecnik J, Kodet R: Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Virchows Arch. 2002, 440: 353-361. 10.1007/s00428-001-0552-2.View ArticlePubMedGoogle Scholar
- Takeda Y, Tsuta K, Shibuki Y, Hoshino T, Tochigi N, Maeshima AM, Asamura H, Sasajima Y, Ito T, Matsuno Y: Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. Arch Pathol Lab Med. 2008, 132: 239-243.PubMedGoogle Scholar
- Gomez-Fernandez C, Mejias A, Walker G, Nadji M: Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung, the antibody factor. Appl Immunohistochem Mol Morphol. 2010, 18: 137-141. 10.1097/PAI.0b013e3181bec23b.View ArticlePubMedGoogle Scholar
- Striebel JM, Dacic S, Yousem SA: Gross cystic disease fluid protein-(GCDFP-15): expression in primary lung adenocarcinoma. Am J Surg Pathol. 2008, 32: 426-432. 10.1097/PAS.0b013e318157a5a6.View ArticlePubMedGoogle Scholar
- Bhargava R, Beriwal S, Dabbs DJ: Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol. 2007, 127: 103-113. 10.1309/TDP92PQLDE2HLEET.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.